cyclosporine has been researched along with Obesity, Morbid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aarabi, M; Allabi, AC; Almond, LM; Ghobadi, C; Jamei, M; Johnson, TN; Rostami-Hodjegan, A; Rowland-Yeo, K | 1 |
| Arias, M; Domínguez-Diez, A; Fernández-Escalante, C; Fernández-Fresnedo, G; Gómez-Fleitas, M; González-Noriega, M; López Deogracias, M; Olmedo, F; Palomar-Fontanet, R; Rodrigo, E; Zubimendi, JA | 1 |
| Alexander, JW; First, MR; Hariharan, S; Marterre, WF | 1 |
| Anjum, MR; Bowley, JN; Drafts, HH; Humphries, AL; Mulloy, LL; Wynn, JJ | 1 |
| Fisher, RK; Flechner, SM; Haug, M; Modlin, CS | 1 |
| Ablassmaier, B; Jacobi, CA; Klaua, S; Müller, JM | 1 |
6 other study(ies) available for cyclosporine and Obesity, Morbid
| Article | Year |
|---|---|
Application of a systems approach to the bottom-up assessment of pharmacokinetics in obese patients: expected variations in clearance.
Topics: Adolescent; Adult; Aged; Benzodiazepines; Body Weights and Measures; Caffeine; Chlorzoxazone; Computer Simulation; Cyclosporine; Female; Gastrointestinal Tract; Humans; Kidney; Liver; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Obesity; Obesity, Morbid; Pharmacokinetics; Phenytoin; Regional Blood Flow; Theophylline; Young Adult | 2011 |
Biliopancreatic diversion in a renal transplant patient.
Topics: Amyloidosis; Biliopancreatic Diversion; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Obesity, Morbid | 2007 |
Gastric bypass in morbidly obese kidney transplant recipients.
Topics: Adult; Cyclosporine; Diabetes Mellitus; Female; Gastric Bypass; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Obesity, Morbid; Retrospective Studies; Weight Loss | 1996 |
The impact of pre-transplant obesity on renal transplant outcomes.
Topics: Adult; Azathioprine; Body Mass Index; Cadaver; Cyclosporine; Diabetes Mellitus; Female; Glucocorticoids; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Mycophenolic Acid; Obesity; Obesity, Morbid; Prednisone; Surgical Wound Infection; Survival Rate; Transplantation, Homologous; Treatment Outcome; Weight Gain | 1997 |
Cyclosporine disposition and long-term renal function in a 500-pound kidney transplant recipient.
Topics: Biological Availability; Cadaver; Cyclosporine; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Failure, Chronic; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Obesity, Morbid | 1998 |
Laparoscopic gastric banding after heart transplantation.
Topics: Bandages; Cyclosporine; Gastroplasty; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Laparoscopy; Male; Middle Aged; Obesity, Morbid | 2002 |